Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenabasum in Cystic Fibrosis
NCT02465450Phase 2Completed
- Sponsor
- Corbus Pharmaceuticals Holdings, Inc.
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of lenabasum in cystic fibrosis (CF), sponsored by Corbus Pharmaceuticals Holdings, Inc.. Started Sep 2015; status: completed.
02
Drugs
lenabasum
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02465450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465450.